Trial Profile
Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 29 Oct 2011
Price :
$35
*
At a glance
- Drugs Tobramycin (Primary) ; Aztreonam
- Indications Bacterial infections; Cystic fibrosis-associated respiratory tract infections
- Focus Pharmacodynamics
- Sponsors Novartis Pharmaceuticals
- 29 Oct 2011 New trial record